Skip to main content

Table 2 The characteristics of 538 CRC patients from TCGA

From: Multi-omics analyses of human colorectal cancer revealed three mitochondrial genes potentially associated with poor outcomes of patients

  Type Patients
Fustat Alive 431 (80.1%)
Dead 107 (19.9%)
Age ≤ 65 232 (43.1%)
> 65 306 (56.9%)
Type Adenocarcinoma 538 (98.5%)
Not clear 8 (1.5%)
Sex Male 254 (47.2%)
Female 284 (52.8%)
Stage I 95 (17.7%)
II 208 (38.7%)
III 149 (27.6%)
IV 86 (16.0%)
T-stage T1 17 (3.2%)
T2 92 (17.1%)
T3 372 (69.1%)
T4 57 (10.6%)
M-stage M0 452 (84.0%)
M1 86 (16.0%)
N-stage N0 313 (58.2%)
N1 128 (23.8%)
N2 97 (18.0%)
Location Colon 389 (72.3%)
Rectum 141 (26.2%)
Not clear 8 (1.5%)